itraconazole and Graft vs Host Disease
itraconazole has been researched along with Graft vs Host Disease in 17 studies
Research
Studies (17)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 9 (52.94) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Block, C; Moses, AE; Or, R; Shapira, MY; Strahilevitz, J; Tzadok, R | 1 |
Bouza, E; Escribano, P; Guinea, J; Montilla, P; Muñoz, P; Padilla, B | 1 |
Akashi, K; Ikesue, H; Masuda, S; Matsukawa, K; Miyamoto, T; Shiratsuchi, M; Suetsugu, K; Tsuchiya, Y; Uchida, M; Watanabe, H; Yamamoto-Taguchi, N | 1 |
Anasetti, C; Field, T; Gergis, U; Greene, J; Huang, Y; Kharfan-Dabaja, M; Markey, K; Perkins, J; Schell, MJ; Wetzstein, G | 1 |
Kagaya, H; Miura, M; Nara, M; Saitoh, H; Sawada, K; Takahashi, N | 1 |
Langston, AA; O'Sullivan, AK; Pandya, A; Papadopoulos, G; Perfect, JR; Thompson, D; Weinstein, MC | 1 |
Balajee, SA; Boeckh, M; Corey, L; Crippa, F; Hoyle, M; Leisenring, W; Marr, KA; Musher, B; Nichols, WG | 1 |
Brown, M; Grigg, AP; Roberts, AW; Slavin, MA; Szer, J | 1 |
Jagirdar, J; Scott, RS; Sutton, DA | 1 |
De Pauw, BE; Donnelly, JP | 1 |
Arima, F; Eto, T; Gondo, H; Kamo, M; Kato, K; Muta, T; Nawata, R; Okeda, A; Oku, S; Shibuya, T; Takase, K | 1 |
Geha, DJ; Goldberg, SL; Hoagland, HC; Inwards, DJ; Marshall, WF | 1 |
Baddley, JW; Moser, SA; Pappas, PG; Sutton, DA | 1 |
Ali, LI; Carter, TH; Roy, V; Selby, GB | 1 |
Andersson, BS; Kontoyiannis, DP; Lewis, RE; Raad, II | 1 |
Grigg, A | 1 |
Blume, KG; Denning, DW; Stepan, DE; Stevens, DA | 1 |
Reviews
1 review(s) available for itraconazole and Graft vs Host Disease
Article | Year |
---|---|
Prophylaxis and treatment of patients with aspergillosis: an overview, including the Royal Melbourne Hospital experience.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Cross Infection; Graft vs Host Disease; Humans; Itraconazole; Risk Factors; Victoria | 2002 |
Trials
4 trial(s) available for itraconazole and Graft vs Host Disease
Article | Year |
---|---|
Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease.
Topics: Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Models, Economic; Mycoses; Severity of Illness Index; Transplantation, Homologous; United States | 2012 |
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.
Topics: Adult; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Female; Fluconazole; Graft vs Host Disease; Humans; Incidence; Itraconazole; Male; Stem Cell Transplantation; Treatment Outcome | 2004 |
A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Liposomes; Male; Middle Aged; Pilot Projects; Risk Factors; Transplantation, Homologous | 2004 |
The consequences of tacrolimus blood concentrations during the four weeks following marrow transplantation from an unrelated donor: a single-center experience.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Female; Graft vs Host Disease; Humans; Itraconazole; Male; Middle Aged; Survival Rate; Tacrolimus; Time Factors; Tissue Donors; Transplantation, Homologous | 2008 |
Other Studies
12 other study(ies) available for itraconazole and Graft vs Host Disease
Article | Year |
---|---|
Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Clinical Protocols; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pharmaceutical Solutions; Survival Rate; Transplantation, Homologous; Voriconazole; Young Adult | 2015 |
Genotyping of Aspergillus fumigatus Reveals Compartmentalization of Genotypes in Disseminated Disease after Invasive Pulmonary Aspergillosis.
Topics: Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillus fumigatus; Female; Genotype; Graft vs Host Disease; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Typing; Mycological Typing Techniques; Triazoles; Voriconazole | 2017 |
Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.
Topics: Administration, Oral; Adult; Aged; Allografts; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Itraconazole; Male; Middle Aged; Retrospective Studies; Tacrolimus; Voriconazole | 2017 |
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.
Topics: Adult; Antifungal Agents; Chemoprevention; Female; Fluconazole; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3.
Topics: Administration, Oral; Alleles; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Capsules; Combined Modality Therapy; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dacarbazine; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Graft vs Host Disease; Half-Life; Hodgkin Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Intestines; Itraconazole; Methotrexate; Tacrolimus; Transplantation, Homologous; Vinblastine; Young Adult | 2010 |
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2005 |
Prophylaxis and aspergillosis--has the principle been proven?
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Mycoses; Neutropenia; Opportunistic Infections; Triazoles | 2007 |
Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Bone Marrow Transplantation; Debridement; Graft vs Host Disease; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lung; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycetoma; Opportunistic Infections; Pseudallescheria; Tomography, X-Ray Computed; Transplantation, Autologous | 1993 |
Microascus cinereus (Anamorph scopulariopsis) brain abscess in a bone marrow transplant recipient.
Topics: Adult; Amphotericin B; Ascomycota; Bone Marrow Transplantation; Brain Abscess; Central Nervous System Fungal Infections; Craniotomy; Drug Combinations; Female; Graft vs Host Disease; Humans; Itraconazole; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Drug Combinations; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lymphoma, Follicular; Male; Mucormycosis; Opportunistic Infections; Pancytopenia; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bone Marrow Transplantation; Drug Therapy, Combination; Graft vs Host Disease; Humans; Itraconazole; Male; Treatment Outcome | 2001 |
Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Female; Graft vs Host Disease; Hepatitis B; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Myelodysplastic Syndromes | 1992 |